storage and handling of unused stem cell products Swiss consensus?



Similar documents
Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood

MEDICAL COVERAGE POLICY

CORD BLOOD TRANSPLANTATION STUDY EXPANDED ACCESS PROTOCOL APPENDIX A SAMPLE CONSENT FORM

OUR JOURNEY THROUGH THE YEARS

Reference: NHS England B04/P/a

EUROCORD. in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases

Hematopoietic Stem Cell Transplantation. Imad A. Tabbara, M.D. Professor of Medicine

Data Reporting Problems

Stem Cell Transplantation

Bone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation: Questions and Answers. Key Points

INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR

Corporate Medical Policy

Corporate Medical Policy

Bone Marrow/Stem Cell Transplant

Pro Cure in Multiple Myeloma. Nicolaus Kröger Dept. of Stem Cell Transplantation University Hospital Hamburg Hamburg, Germany

What is a Stem Cell Transplantation?

Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation. April Reference: NHSCB/B04/P/a

UMBILICAL CORD BLOOD BANKING. A guide for parents

Chapter 4 Section High Dose Chemotherapy (HDC) And Stem Cell Transplantation

Challenges of Hematopoietic Stem Cell Transplantation. Robert J. Soiffer, MD Dana Farber Cancer Institute

WBMT Global Survey. Helen Baldomero Cape Town November Worldwide Network for Blood and Marrow Transplantation

CPT Codes for Bone Marrow Transplant January 2015 James L. Gajewski, MD

H. R IN THE HOUSE OF REPRESENTATIVES

DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT

Blood-Forming Stem Cell Transplants

Lauren Berger: Why is it so important for patients to get an accurate diagnosis of their blood cancer subtype?

UMBILICAL CORD BLOOD HARVESTING & STORAGE

STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA

It s not something you want to think about, but it s something you want to prepare for.

Cord Blood Stem Cell Transplantation

UMBILICAL CORD BLOOD BANKING A guide for parents

cancer cancer Hessamfar-Bonarek M et al. Int. J. Epidemiol. 2010;39:

I was just diagnosed, so my doctor and I are deciding on treatment. My doctor said there are several

Infosheet. Allogeneic stem cell transplantation in myeloma. What is the principle behind stem cell transplantation?

Bendamustine for the fourth-line treatment of multiple myeloma

Pr Eliane Gluckman, MD, FRCP, Disclosure of Interest: Nothing to Disclose

How To Support Umbilical Cord Blood Stem Cell Research

Treatment of low-grade non-hodgkin lymphoma

The Infinite Potential of Stem Cell Japan s Cord Blood Bank and Transplant

Talking With Your Doctor About Multiple Myeloma: A guide to making the most of your healthcare visits

2011 Update on the ECIL-3 guidelines for EBV management in patients with leukemia and other hematological disorders

The Facts about Cord Blood

The CIBMTR Audit Program

Hematopoietic Stem Cells, Stem Cell Processing, and Transplantation

Acute Myeloid Leukemia Therapeutics Market to 2020

4/25/2016. Transplant Journey. Objectives. Reason for Transplantation at Mayo Clinic. Mayo Clinic Model of Care

CSHCN Services Program Prior Authorization Request for Stem Cell or Renal Transplant Form and Instructions

Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris

CAR T cell therapy for lymphomas

Collaboration to collect Autologous transplant outcomes in Lymphoma and Myeloma (CALM) Additional Questionnaire (MED C) INCLUSION CRITERIA CALM STUDY

Donating stem cells. What s involved?

How To Treat Leukaemia With Cord Blood Stem Cell

The ethics of stem cell research and treatment

4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.

Disclosures. I have no disclosures.

Stem Cell Transplantation in Adults

New Zealand Bone Marrow Donor Registry

5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.

Cord blood donation is a painless and free gesture, helping others and saving lives.

MorphoSys Proprietary Development Update

guides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research

What we will discuss today

Acute myeloid leukemia (AML)

Informed Consent in Umbilical Cord Blood Collection, Storage and Donation: A Bloody Mess

STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA

UMBILICAL CORD BLOOD, STEM CELL BANKING

On April 4, a group of physicians at the 37th annual

House Resolution No. 37

cord blood saves lives...

Donate your baby s cord blood and save lives.

Q: Why is there a need for people to join the Be The Match Registry?

How To Save A Patient From A Cancer

PROTOCOLS FOR TREATMENT OF MALIGNANT LYMPHOMA

Hodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla

CBAN: Cord Blood Education Guide. CBANetwork. Cord Blood Advocacy Network

Stem cells from Cord Blood: Myths, reality and potential. Elisabeth Semple, PhD Scientific Director Cells for Life Cord Blood Institute

PART I. SECTION 1. The legislature finds that an estimated. 128,000,000 Americans suffer from the crippling economic and

Blood and Marrow Stem Cell Transplantation

Pharmacoeconomic Analyses and Oncology Pharmacy: Optimizing Multiple Myeloma Value for Patients and Plans

Umbilical Cord Blood Stem Cells Current Status & Future Potential

SAVE A LIFE... BY GIVING LIFE!

STEM CELL TRANSPLANTS

Peripheral Blood Stem Cell (PBSC) Collections: Why, What, When. Objectives. Sources of Stem Cells

Transcription:

storage and handling of unused stem cell products Swiss consensus? 16. Jan. 2015 Panagiotis Samaras, Mario Bargetzi

stored units USZ

Type of unused product autologous stem cells never transplanted 2nd transplant (tandem, relapse) autologous back up in allogeneic transplanted patients donor lymphocytes (DLI) directed/targeted cord blood engineered cells (mesenchymal, NK)

patient related reasons for unused products response after first HD-chemotherapy disease progression prior to stem cell transplantation age of the patient deceased patients

Poll in Swiss centers

recomendations there should be a written policy dealing with storage, disposal and use for research purposes of unused stem cell products this policy should be part of the informed consent for high dose chemotherapy and stem cell transplantation, handed to the patient before collection of stem cells unused stem cell products of deceased patients should be disposed of for patients alive the duration of storage of unused stem cells should be at least 5 years disposal after 5 years of storage should only be done after discussion with the treating physician advanced age by itself is not a reason to discard unused stem cells Comorbidities, that preclude high dose chemotherapy and stem cell transplantation are a reason to discard unused stem cells storage duration should not be different for different diseases unused autologous back ups can be discarded after 5 years??? DLI??? stored unlimited instead of disposal unused stem cells can be used for research, if patient gave informed consent

Questionnaire Stem Cell Storage in Swiss Centers time period from 01/2004 to 12/2013 How many and what patients had long-term stored bags after rainy day collection (>1 year) before their first ASCT? ASCT after 1 to 5 years of storage (n, % of all stored products)? 0, 6 Entities of these transplanted patients? Lymphoma, solid tumors, AML? Patient Age? ASCT after 6 to 10 years of storage (n, % of all stored products)? 0, 1 Ly Entities of these transplanted patients? Patient age? ASCT after 10 years of storage (n, % of all stored products)? 0 Entities of these transplanted patients? Patient age?

How many and what patients had long-term stored bags after rainy day collection (>1 year) and NEVER received an ASCT? Storage for 1 to 5 years (n, % of all stored products)? 30 (Ly, AML, MM, Tu) Entities of these never-transplanted patients? Patient age? Storage for 6 to 10 years (n, % of all stored products)? 43 (Ly, AML, MM, Tu) Entities of these never-transplanted patients? Patient age? Storage for over 10 years (n, % of all stored products)? 15 (Ly, AML, MM, Tu) Entities of these never-transplanted patients? Patient age?

How many patients received a second transplant as salvage with stored bags? 1-5 years after the first ASCT? 14, 38 Entities? All MM Patient age? Mean 55 (range 27 67) at 1 st transplant 6-10 years after the first ASCT? 2, 3 Entities? All MM Patient age? 57, 58 at 1 st transplant >10 years after the first ASCT? 0

How many patients NEVER received a second transplant as salvage and have still bags? Storage for 1-5 years after the first ASCT? 33, 48 Entities? MM, (1Ly, 1 Tu) Patient age? Mean 56.2 y (range 37 68) Storage for 6-10 years after the first ASCT? 14, 43 Entities? MM, (2 Tu) Patient age? Mean 59.4 (range 47 69) Storage for >10 years after the first ASCT? 0, 3 Entities? MM Patient age?

What patients had their bags disposed at that time period? Entities? 22, 100 patients, all MM, > 90 % death, < 10 % >7y Reasons for disposal (i.e. death, age of patient, age of bag, contraindications for ASCT, Damaged bag, other reason)? Transplanted or NEVER transplanted patient? All transplanted

27 % units unused at follow up > 3 years 41 % of patients reinfused with all units < 1 % after 2 years of storage before transplantation in leukemia < 2 % in patients with myeloma or lymphoma

we should finally get there please send all data thank you